Business Standard

Gland Pharma's Rs 6,480-crore IPO subscribed 21% a day ahead of close

Offering received bids for 6.4 mn shares as against 30 mn on offer

Representative Image (Photo: Shutterstock)
Premium

Representative Image (Photo: Shutterstock)

BS Reporter Thiruvananthapuram
Gland Pharma’s initial public offering (IPO) was subscribed 21 per cent on Tuesday, a day before its close. 

The offering has received bids for 6.4 million shares as against 30 million on offer. China’s Fosun Pharma-promoted firm is looking to raise Rs 1,250 crore through the IPO by issuing new shares. 

The IPO also comprises of secondary share sale worth Rs 5,230 crore. The total IPO size is about Rs 6,480-crore, making it one of the biggest pharma IPO in the domestic market. 

The company has already allotted shares worth Rs 1,944 crore worth to anchor investors. The price band has been set

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in